Central Florida Pulmonary Group, PA is a clinical research site located in Orlando, Florida, United States 32803.
Crixeo Clinical Trials Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
Central Florida Pulmonary Group, PA has participated in 25 clinical trials with 3 currently active.
Therapeutic areas: Alpha 1-Antitrypsin Deficiency, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis.
Sponsors: Vertex Pharmaceuticals Incorporated, Kadmon Corporation, LLC, United Therapeutics.
Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Central Florida Pulmonary Group, PA has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Central Florida Pulmonary Group, PA has 25 clinical trials on record, with 3 currently active. Their work covers Alpha 1-Antitrypsin Deficiency, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis.
Central Florida Pulmonary Group, PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.